August 29, 2012
Pliva Inc. and two other generic-drug makers have won the dismissal of a suit in Louisiana federal court that claimed a woman's movement disorder was caused by generic Reglan, ruling design defect and other allegations are preempted by the U.S. Supreme Court decision in Pliva Inc. v. Mensing.